Skip to main navigation
Skip to search
Skip to main content
Icahn School of Medicine at Mount Sinai Home
Help & FAQ
Link opens in a new tab
Search content at Icahn School of Medicine at Mount Sinai
Home
Profiles
Research units
Publications & Research Outputs
Press/Media
Treatment of regionally advanced bladder cancer: An overview
M. J. Droller
Icahn School of Medicine at Mount Sinai
Urology
Research output
:
Contribution to journal
›
Review article
›
peer-review
6
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Treatment of regionally advanced bladder cancer: An overview'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
5-year Survival
100%
Bladder Cancer
100%
Advanced Bladder Cancer
100%
Better Prognosis
50%
Vasculature
50%
Systemic Chemotherapy
50%
Lymphatics
50%
Poor Prognosis
50%
Distant Metastasis
50%
Bladder Wall
50%
Papillary Architecture
50%
Medicine and Dentistry
Bladder Cancer
100%
Survival Rate
50%
Lymph Duct
25%
Vascularity
25%
Distant Metastasis
25%
Bladder Wall
25%
Chemotherapy
25%
Pharmacology, Toxicology and Pharmaceutical Science
Bladder Cancer
100%
Survival Rate
50%
Distant Metastasis
25%
Chemotherapy Regimens
25%
Engineering
Survival Rate
100%
Chemotherapy
50%
Biochemistry, Genetics and Molecular Biology
Survival Rate
100%
Vascularization
50%
Material Science
Metastatic Carcinoma
100%